Search
forResearch 10 of 1000+
- A Prospective Study on Trichoscopy as a Diagnostic and Monitoring Tool for Assessment of Therapeutic Response in Patients with Tinea Capitis
- Serum IFNα as a Biomarker for Cutaneous Lupus: Insights into Disease Activity, Severity, Therapeutic Monitoring and Clinical Trial Application
- Benefits of Testosterone Replacement and Methods of Substitution
- Development of an improved method to estimate the days of continuous drug ingestion, based on the micro‐segmental hair analysis
- The efficacy and safety of valproic acid medications with controlled active ingredient release in adults in real clinical practice from the position of pharmacokinetic and pharmacogenetic approaches
- Supplemental Material: Tolerability and Efficacy of Unorthodox Dosing Regimens of Tofacitinib and Baricitinib in Pediatric Patients with Moderate to Severe Alopecia Areata
- 476 Development of an intrinsic skin sensor for blood glucose level with CRISPR-mediated genome editing in epidermal stem cells
- Transnasal cooling: A Pandora’s box of transnasal patho-physiology
- 586 Increase in CD8+ effector memory cells re-expressing CD45RA (TEMRA) reflects disease activity and enables early prediction of therapeutic outcome in rapidly progressive alopecia areata
- Insights into the Diagnostics and Therapeutics of Alopecia Areata—An Indian Context
Learn 1 of 5
All learn results →Community 6 of 15
- mallia therapeutics 8T3 scd83 molecule for ffa/lpp mainly and aga
- The Chinese version of Stemson Therapeutics (Hair Multiplication) is here. It is called Yunce Medical.
- Eirion Therapeutics Announces Potential Breakthrough Treatment for Hair Loss Based on First-in-Man Clinical Trial Results
- Horrible news, Stemson Therapeutics has shut down
- Stemson Therapeutics Announces Technological Breakthrough in new Hair Growth
- IGFBP‐rP1 is a potential therapeutic target in androgenic alopecia